The clinical field studies of malaria-exposed adults have suggested that CSP-specific long-duration IFN-γ ELISPOT levels, rather than CSP-specific short-duration IFN-γ ELISPOT levels, are associated with protection against parasitemia and clinical disease, such as over one malaria season of five months.50 This evidence concerns the gene IFNG and parasitic infectious disease.